| Spanish Prospective Registry of Hydra THV for Transcatheter Aortic Valve Implantation (NCT07566624) | Fundación EPIC | 2026-07-07 |
| LONG NAGOMI™ PMCF STUDY (NCT07399002) | Fundación EPIC | 2026-02-27 |
| Comparison of the Amplatzer Amulet Versus LAmbre Device for Left Atrial Appendage Closure (NCT07260474) | Fundación EPIC | 2026-01-30 |
| A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial) (NCT07286578) | Fundación EPIC | 2025-12-22 |
| Comparison of a Contemporary Sirolimus-eluting Stent (ihtDEStiny®) With Another Everolimus-eluting Stent (Xience™), Both With Permanent Polymers, in Patients With Acute Coronary Syndrome and de Novo Coronary Artery Lesions (NCT07190690) | Fundación EPIC | 2025-12-19 |
| Real-life Registry in Patients With Coronary Artery Disease Treated With the SELUTION Sirolimus-eluting Balloon. Selution Iberia Registry (NCT07256249) | Fundación EPIC | 2025-12-11 |
| Essential Pro Study ( rEPIC04E-HK ) (NCT06631157) | Fundación EPIC | 2025-05-15 |
| Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation (NCT06863155) | Fundación EPIC | 2025-05-06 |
| Results of the Use of Two Stentrievers Simultaneosly Compared With One as a Primary Treatment in Acute Ischemic Stroke (NCT05930145) | Fundación EPIC | 2025-03-14 |
| DEBSCAN-IVL. Drug Eluting Balloon or Drug Eluting Stent to Treat CAlcified Nodules After IntraVascular Lithotripsy. (NCT06657833) | Fundación EPIC | 2024-12-17 |
| Influence of Vessel Wall Calcification on Early Stent Strut Healing (NCT06631755) | Fundación EPIC | 2024-11-07 |
| DRUG RELEASING BALL vs. PHARMACOACTIVE STENT IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) IN LARGE VESSELS: MORPHOLOGICAL ANALYSIS AND FUNCTION VASOMOTOR (DEBORA STUDY) (NCT06448637) | Fundación EPIC | 2024-10-23 |
| Safety and Effectiveness of Short-Term Single AntiPlatelet Therapy After Left Atrial Appendage Closure With the LAmbre Device in Patients With Nonvalvular Atrial Fibrillation: A Multinational Real-world Registry (NCT06620757) | Fundación EPIC | 2024-10-10 |
| Postprocedural Contrast Mediated FFR Plus Intracoronary Infusion of Nitroglycerin in Multivessel Patients (PROMETEUS TRIAL) (NCT06273293) | Fundación EPIC | 2024-05-31 |
| Comparison Between Optical Coherence Tomography and Intravascular Ultrasound for Intermediate Left Main Coronary Artery Lesions (NCT06272643) | Fundación EPIC | 2024-04-04 |
| Plan to Evaluate Early Endothelialization of a Polymer Free Sirolimus-eluting Coronary Stent System (VIVO ISARTM) Compared With Everolimus-eluting Durable Polymer Stent (XIENCE SkypointTM) in Patients Undergoing Percutaneous Coronary Intervention. (NCT06214819) | Fundación EPIC | 2024-03-20 |
| PREVAIL Paclitaxel-coated Balloon in Small Coronary Disease and High-bleeding Risk Patients (NCT06321757) | Fundación EPIC | 2024-02-26 |
| Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication (NCT06049654) | Fundación EPIC | 2024-02-01 |
| SUPRAFLEX CRUZ PMCF Study ( rEpic05 ) (NCT05617599) | Fundación EPIC | 2023-05-10 |
| Evaluation of the Viability and Safety of Early Discharge Protocol After TAVI Implantation (NCT05758909) | Fundación EPIC | 2023-04-04 |
| Sequent Extended Study (NCT05788432) | Fundación EPIC | 2023-03-28 |
| NAVISCORE PMCF Study ( rEPIC04F ) (NCT05706805) | Fundación EPIC | 2023-01-31 |
| Treatment of Functionally Non-significant Vulnerable Plaques in Patients With Multivessel ST-elevation Myocardial Infarction The VULNERABLE Trial (NCT05599061) | Fundación EPIC | 2023-01-30 |
| Xperience Pro PMCF Study (NCT05292144) | Fundación EPIC | 2022-10-26 |
| Cross-over Study of Coronary Risk Factors With a Polypill (NCT05030818) | Fundación EPIC | 2022-10-14 |
| CAPTURER PMCF Study ( rEPIC04D ) (NCT05292079) | Fundación EPIC | 2022-09-29 |
| NC Xperience PMCF Study( rEPIC04B) (NCT05292105) | Fundación EPIC | 2022-09-26 |
| ANGIOLITE PMCF Study ( rEPIC04F ) (NCT05292014) | Fundación EPIC | 2022-09-26 |
| Essential Pro PMCF Study ( rEPIC04E ) (NCT05292092) | Fundación EPIC | 2022-09-26 |
| Navitian PMCF Study ( rEPIC04C ) (NCT05292118) | Fundación EPIC | 2022-09-26 |
| Parenteral Antiplatelet Agents in Real-world Spanish PCI Patients (NCT05193019) | Fundación EPIC | 2022-03-14 |
| Double Rewire Versus Double Kissing Crush Stenting Technique in Left Main Bifurcation Lesions (NCT05258318) | Fundación EPIC | 2022-02-20 |
| Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice (NCT04899141) | Fundación EPIC | 2021-10-29 |
| VerifyNow to Optimise Platelet Inhibition in Coronary Acute Syndrome (NCT04654052) | Fundación EPIC | 2021-07-02 |
| ANGiographic Evaluation of Left Main Coronary Artery INtErvention (NCT04604197) | Fundación EPIC | 2021-04-16 |
| Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia (NCT04685941) | Fundación EPIC | 2021-01-25 |
| Laser-excimer Versus High-pressure Dilation to Treat Under-expansion of the Stent (NCT04359446) | Fundación EPIC | 2020-09-12 |
| A Prospective Study, Single-arm, Multicentre, Observational to Evaluate Safety and Effectiveness of Stent Ultimaster Tansei Coronary Stent in Complex Coronary Lesions. (NCT04475536) | Fundación EPIC | 2020-08-21 |
| Evaluation of Ambulatory Monitoring of Patients After High-risk Acute Coronary Syndrome Using Two Different Systems: Biomonitor-2 and Kardia Mobile (NCT03940066) | Fundación EPIC | 2019-11-12 |
| PRospective Evaluation Complementing Investigation With Acurate Neo Device (NCT03846557) | Fundación EPIC | 2019-05-20 |
| Evaluation of Lifestyle Education and Events Via Network Text Messages After Acute Coronary Syndrome (NCT07331415) | Fundación EPIC | 2019-05-01 |
| Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR (NCT03767621) | Fundación EPIC | 2019-02-19 |
| Evaluation of the Safety and Efficacy of Titanium-nitric Oxide-coated Stent (Optimax®) in Patients With Lesions With a Low Risk of Restenosis (Diameter ≥ 3.0 mm and Length ≤ 20 mm) (NCT03737565) | Fundación EPIC | 2019-02-17 |
| Prospective Registry of Patients Over 75 Years Old Treated With Xience Sierra Stents. Sierra 75 Study (NCT03567733) | Fundación EPIC | 2018-06-18 |
| Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis (NCT03446794) | Fundación EPIC | 2018-03-14 |